Treatment of extravasation of both doxorubicin and vincristine administration in a Y-site infusion

Annals of Pharmacotherapy

Volumn 30, Issue 3, 1996, Pages 244-246

  Comas, Dolors ^a   Mateu, Javier ^a  

^a HOSPITAL UNIVERSITARI JOAN XXIII   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOTOXIC AGENT; DEXAMETHASONE; DIMETHYL SULFOXIDE; DOXORUBICIN; N ACETYLGALACTOSAMINE 4 SULFATASE; VINCRISTINE;

AGED; ARTICLE; CLINICAL ARTICLE; CONTINUOUS INFUSION; ERYTHEMA; EXTRAVASATION; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MULTIPLE MYELOMA; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION; TOPICAL DRUG ADMINISTRATION;

EID: 0030009482     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1177/106002809603000306     Document Type: Article

References (15)

1. Rudolph R, Larson DL. Etiology and treatment of chemotherapeutic agent extravasation injuries: a review. J Clin Oncol 1987;5:1116-26.
2. Cox K, Stuart-Harris R, Abdini G, Grygiel J, Raghavan D. The management of cytotoxic-drug extravasation: guidelines drawn up by a working party for the Clinical Oncological Society of Australia. Med J Aust 1988;148:185-9.
3. Dorr RT. Antidotes to vesicant chemotherapy extravasations. Blood Rev 1990;4:41-60.
4. Samson D, Newland A, Kearney J, Joyner M, Mitchell T, Barrett AJ, et al. Infusion of vincristine and doxorubicin with oral dexamethasone as first line therapy for multiple myeloma. Lancet 1989;14:882-5.
5. Barlogie B, Smith L, Alexanian R. Effective treatment of advanced multiple myeloma refractory to alkylating agents. N Engl J Med 1984;310:1353-6.
6. Sonnevel P, Durie BG, Lokhorst HM, Marie JP, Solbu G, Suciu S, et al. Modulation of multidrug-resistant multiple myeloma by cyclosporin. Lancet 1992;340:255-9.
7. Llop JC, Mateu J, Llorente A. Extravasación de fármacos citostáticos: diagnóstico, evolución y tratamiento. Med Clin (Barc) 1993;101:105-9.
8. Upton J, Mulliken JB, Murray JE. Major intravenous extravasation injuries. Am J Surg 1979;137:497-506.
9. Bertelli G, Dini D, Forno GB, Gozza A, Silvestro S, Venturini M, et al. Hyaluronidase as an antidote to extravasation of vinca alkaloids: clinical results. J Cancer Res Clin Oncol 1994;120:505-6.
10. Olver IN, Aisner J, Hament A, Buchanan L, Bishop IF, Kaplan RS. A prospective study of topical dimethyl sulfoxide for treating anthracycline extravasation. J Clin Oncol 1988;6:1732-5.
11. Bertelli G, Dini D, Forno G, Gozza A, Venturini M, Ballella G, et al. Dimethylsulphoxide and cooling after extravasation of antitumour agents (letter). Lancet 1993;341:1098-9.
12. Reynolds JEF, ed. Martindale: the extra pharmacopoeia. 30th ed. London: Pharmaceutical Press, 1993:1420.
13. Hajanzadeh H, Lebredo L, Barrie R, Eugene A, Woltering EA. Protective effect of doxorubictn in vitamin C or dimethyl sulfoxide against skin ulceration in the pig. Ann Surg Oncol 1994;1:411-4.
14. Dorr RT, Alberts DS. Pharmacologic antidotes to experimental doxorubicin skin toxicity: a suggested role for beta-adrenergic compounds. Cancer Treat Rep 1981;65:1001-6.
15. Mateu J, Llop C. Delayed treatment of vindesine extravasation (letter). Ann Pharmacother 1994;28:967-8.